Colgate-Palmolive (CL) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.97
- Estimate
- $0.93
- Surprise
- +4.8%
- Revenue (period 2026-09-30)
- $5.37B
- Score at report (before → after)
- 5.1 → 5.3/10
Revenue source: xbrl.
How the report landed
Colgate-Palmolive (CL) beat the $0.93 estimate with adjusted EPS of $0.97 — a clear 4.8% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.1/10) to Hold at 5.3/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CL Sell at 5.3/10.
4 of the last 4 quarters beat the estimate; this quarter's +4.8% surprise compares with a +4.1% four-quarter average. Next scheduled report: 2027-01-29.
What supports the rating
- Sector modifier (Consumer Defensive): +1.0
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (3.0% away)
- Leverage penalty (D/E 12.1): -1.5
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $98.71
- Stop
- $94.23
The stock trades at 37.7× trailing but 23.6× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-20 — shown for context, not personalized investment advice.
CL at TrendMatrix's latest read
Defensive staples are judged on margin resilience: pricing power against input costs matters more here than top-line drama.
- Industry
- Household & Personal Products
- Market cap
- $77.01B
- P/E (fwd)
- 23.6
- P/E (ttm)
- 37.7
- 52-week range
- $75.96–$101.81
- Off 52-week high
- 3.0%
- RSI (14)
- 54
- Volume vs avg
- 1.18×
- Score today
- 5.3/10